Albany International CFO takes medical leave

Rhea-AI Filing Summary

Albany International Corp. (AIN) reported that its Chief Financial Officer and principal financial officer, Willard Station, has begun a medical leave of absence effective August 31, 2026, and will not perform CFO duties during this period. The duration of the leave has not been determined.

Effective the same date, the Board appointed Sean Valashinas, the company’s Controller and Chief Accounting Officer, to serve as acting principal financial officer while continuing as principal accounting officer. Valashinas, age 55, has extensive prior experience in accounting, treasury, and tax roles at Resonetics and Standex International Corporation. The company states there are no disclosable familial relationships or related party transactions connected to his appointment and no changes to his compensation terms. A press release announcing these changes was furnished as Exhibit 99.1.

Positive

• None.

Negative

• CFO on medical leave with unknown duration, creating near-term leadership uncertainty in the company’s finance function.

8-K Event Classification

3 items: 5.02, 7.01, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Date CFO leave of absence effective: August 31, 2026 Age of acting principal financial officer: 55 Start of Controller and Chief Accounting Officer role: June 9, 2025 +1 more

4 metrics

Date CFO leave of absence effective August 31, 2026 Effective date of Willard Station’s medical leave of absence

Age of acting principal financial officer 55 Age of Sean Valashinas at time of appointment

Start of Controller and Chief Accounting Officer role June 9, 2025 Date Sean Valashinas began serving as Controller and Chief Accounting Officer

Prior employment period at Standex International Corporation 2007 to 2024 Years during which Sean Valashinas worked at Standex International Corporation

Key Terms

principal financial officer, principal accounting officer, Regulation FD Disclosure, related party transactions

4 terms

principal financial officer financial

"the Company's Chief Financial Officer and principal financial officer, will commence"

The principal financial officer is the senior executive who runs a company's financial operations: preparing and certifying financial reports, managing accounting controls, budgets and cash flow, and advising on financial strategy. Investors care about this role because its competence affects how trustworthy the company’s numbers are, how well it manages risk and capital needs, and the credibility of forecasts—like the chief navigator steering a firm's financial course.

principal accounting officer financial

"to serve as the Company’s acting principal financial officer in addition to his role as principal accounting officer"

The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

Regulation FD Disclosure regulatory

"Item 7.01 Regulation FD Disclosure On August 31, 2026, the Company issued"

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

related party transactions financial

"There are no familial relationships or related party transactions with the Company"

Transactions between a company and people or entities that have close ties to it—such as executives, board members, major shareholders, family members, or related companies—where the parties are not independent. These deals matter to investors because they can create conflicts of interest or hide favorable terms that distort a company’s true profits and risks; think of it like a business buying or selling to a family member instead of using the open market, which can lead to biased prices or undisclosed obligations.

FAQ

What leadership change did Albany International Corp. (AIN) announce on August 31, 2026?

Albany International Corp. announced that Chief Financial Officer and principal financial officer Willard Station began a medical leave of absence effective August 31, 2026, during which he will not perform CFO duties. The company has not determined the duration of this leave.

Who is serving as acting principal financial officer at Albany International Corp. (AIN)?

The Board appointed Sean Valashinas, the company’s Controller and Chief Accounting Officer, to serve as acting principal financial officer effective August 31, 2026. He will retain his role as principal accounting officer while assuming these additional responsibilities.

Did Albany International Corp. (AIN) change Sean Valashinas’s compensation with his new role?

No. Albany International Corp. states there are no changes to Sean Valashinas’s compensation terms in connection with his appointment as acting principal financial officer.

Does Albany International Corp. (AIN) report any related party issues with the new acting CFO?

No. The company states there are no familial relationships or related party transactions involving Sean Valashinas that require disclosure under Items 401(d) or 404(a) of Regulation S-K.

How did Albany International Corp. (AIN) communicate the CFO leave and interim appointment?

Albany International Corp. issued a press release dated August 31, 2026, announcing Willard Station’s medical leave and the appointment of Sean Valashinas as acting principal financial officer. The release was furnished as Exhibit 99.1 to the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 09:05 AM Accepted by SEC EDGAR 08/31/2026 - 09:05 AM Learn about SEC filing dates

325 Corporate DrivePortsmouthNew HampshireFALSE0000819793NYSE00008197932026-08-312026-08-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report:    August 31, 2026

(Date of earliest event reported)

ALBANY INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

Delaware			1-10026			14-0462060
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S Employer Identification No.)

325 Corporate Drive Portsmouth, New Hampshire			03801
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code       603-330-5850

None

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.001 par value per share

AIN

The New York Stock Exchange (NYSE)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

☐    Emerging growth company

¨    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a) Leave of Absence of Chief Financial Officer

On August 31, 2026, Albany International Corp. (the "Company") announced that Willard Station, the Company's Chief Financial Officer and principal financial officer, will commence a medical leave of absence effective immediately. During the leave, Mr. Station will not perform the duties of Chief Financial Officer or principal financial officer. The duration of the leave has not been determined.

(b) Appointment of Acting Chief Financial Officer

In connection with Willard Station's leave of absence, also effective August 31, 2026, the Board of Directors of the Company appointed Sean Valashinas, the Company’s Controller and Chief Accounting Officer, to serve as the Company’s acting principal financial officer in addition to his role as principal accounting officer. Mr. Valashinas, age 55, has served as Controller and Chief Accounting Officer at the Company since June 9, 2025. Prior to joining the Company, Mr. Valashinas served as Vice President, Accounting, Treasury, and Tax at Resonetics, a leading manufacturer in the medical device industry. Prior to that, Mr. Valashinas worked for Standex International Corporation, a publicly traded global industrial manufacturing company, from 2007 to 2024, and was its Vice President, Chief Accounting Officer & Assistant Treasurer. Mr. Valashinas is a Certified Public Accountant, who holds an Accounting degree from the University of Scranton, and received an MBA from Boston University.

There are no familial relationships or related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulations S-K in connection with his appointment.

There are no changes to Mr. Valashinas compensation terms.

Item 7.01 Regulation FD Disclosure

On August 31, 2026, the Company issued a press release announcing Willard Station's leave of absence and the appointment of Sean Valashinas as acting Chief Financial Officer.

A copy of the Press Release is attached as Exhibit 99.1 and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are being furnished herewith:

99.1 News release dated August 31, 2026.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			ALBANY INTERNATIONAL CORP.
			By:			/s/ Gunnar Kleveland
			Name:			Gunnar Kleveland
			Title:			President and Chief Executive Officer
						(Principal Executive Officer)

Date: August 31, 2026

EXHIBIT INDEX

Exhibit No.			Description
99.1			News release dated August 31, 2026
104			Inline XBRL cover page.

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2.5 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT 14.5 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 25.7 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 15.1 KB